Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Luna

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
Frontiers in Surgery|July 15, 2022
Women in Neurosurgery: Historical Path to Self-Segregation and Proposal for an Integrated FutureD Garozzo, R Rispoli, F Graziano, et al.
Journal of Critical Care|August 15, 2017
Zika virus-induced neurological critical illness in Latin America: Severe Guillain-Barre Syndrome and encephalitisUgarte Ubiergo Sebastián, Arenas Villamizar Angel Ricardo, Bruno C Alvarez, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F ActivityShilpa Singh, Catherine E Gleason, Min Fang, et al.
Nature|August 20, 2025
Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitorsShilpa Singh, Catherine E Gleason, Min Fang, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
Frontiers in Surgery|July 15, 2022
Women in Neurosurgery: Historical Path to Self-Segregation and Proposal for an Integrated FutureD Garozzo, R Rispoli, F Graziano, et al.
Journal of Critical Care|August 15, 2017
Zika virus-induced neurological critical illness in Latin America: Severe Guillain-Barre Syndrome and encephalitisUgarte Ubiergo Sebastián, Arenas Villamizar Angel Ricardo, Bruno C Alvarez, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F ActivityShilpa Singh, Catherine E Gleason, Min Fang, et al.
Nature|August 20, 2025
Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitorsShilpa Singh, Catherine E Gleason, Min Fang, et al.
Pageof 13